至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunity

EMBO J. 2020-12; 
Sarah L Caddy, Marina Vaysburd, Guido Papa, Mark Wing, Kevin O'Connell, Diana Stoycheva, Stian Foss, Jan Terje Andersen, Annette Oxenius, Leo C James
Products/Services Used Details Operation
Gene Synthesis … At present, it is uncertain whether N-specific antibodies are protective against CoV-2, but for murine coronavirus it has been demonstrated … was achieved by sequencing the variable regions of KL53, synthesising cDNA encod- ing the heavy and light chains (Genscript Inc, USA … Get A Quote

摘要

Nucleoprotein (N) is an immunodominant antigen in many enveloped virus infections. While the diagnostic value of anti-N antibodies is clear, their role in immunity is not. This is because while they are non-neutralising, they somehow clear infection by coronavirus, influenza and LCMV in vivo. Here, we show that anti-N immune protection is mediated by the cytosolic Fc receptor and E3 ubiquitin ligase TRIM21. Exploiting LCMV as a model system, we demonstrate that TRIM21 uses anti-N antibodies to target N for cytosolic degradation and generate cytotoxic T cells (CTLs) against N peptide. These CTLs rapidly eliminate N-peptide-displaying cells and drive efficient viral clearance. These results reveal a new mechanism... More

关键词

TRIM21, antibody, non-neutralising, nucleoprotein, virus